Beta-Cyclodextrin (CAS 7585-39-9): Properties, Inclusion Chemistry and Applications

Beta-cyclodextrin (CAS 7585-39-9) is a seven-glucose ring molecule with an unusual property: it is water-soluble on the outside and oil-loving on the inside. That combination lets it take a poorly soluble, unstable or volatile molecule into its cavity and hold it there, entirely without forming a chemical bond. It is one of the few excipients that changes a formulation’s behaviour purely by geometry, which is why it appears in pharmaceuticals, foods, cosmetics and agrochemicals at once. This article covers what the molecule is, how the inclusion actually works, and how to read a specification for it.

1. Structure: a truncated cone, not a flat ring

Property	Value
CAS	7585-39-9
Formula / MW	C₄₂H₇₀O₃₅ / 1135.0 g/mol (anhydrous)
Glucose units	7, linked alpha-1,4
Cavity diameter	Approximately 6.0-6.5 Å
Exterior	Hydroxyl-rich, hydrophilic
Interior	Lined by the hydrophobic faces of the glucose rings
Water solubility (25 °C)	About 18.5 g/L – the lowest of the three native cyclodextrins

The alpha-1,4 linkage forces the chain into a ring rather than a helix, and the ring is not flat: the primary hydroxyls sit on the narrow face, the secondary hydroxyls on the wide face, and the cavity between them is lined with C-H groups and glycosidic oxygens. The result is a molecule that dissolves in water while offering a non-polar pocket a few Ångströms across.

2. How inclusion works – and what it is not

Inclusion is a physical equilibrium, not a reaction:

CD (free) + guest (free) ⇌ CD·guest (complex)

There is no covalent bond, no new chemical entity, and the guest can leave again. Three consequences follow, and all three matter commercially:

It is reversible. The complex releases its guest when diluted, when the temperature rises, or when a better competitor for the cavity appears. That is exactly what you want for a flavour or a fragrance, and it is a risk for a formulation whose stability depends on the guest staying put.
Stoichiometry is not always 1:1. Small guests can form 2:1 or 1:2 complexes; the ratio has to be established experimentally for each system and it changes the effective cost of the excipient substantially.
It is not encapsulation in the polymer sense. Nothing is coated or entrapped behind a barrier; the guest sits inside a molecular pocket, and this is why the complex can be made in solution, by kneading, by grinding, or by spray drying.

Effect of complexation	Mechanism	Commercial use
Apparent solubility increase	The guest enters the hydrophilic shell, so its own hydrophobicity stops limiting dissolution	Poorly soluble drugs, vitamins, antioxidants
Stability increase	The reactive part of the guest is shielded from oxygen, light or another component	Oxidation-sensitive oils, flavour compounds
Volatility reduction	The guest is held in the cavity rather than evaporating	Flavour and fragrance retention, aroma encapsulation
Taste and odour masking	The guest no longer contacts the taste receptors	Bitter actives, fish-oil type ingredients
Liquid to powder conversion	The complex is a free-flowing solid	Essential oils and other liquids handled as powders

3. Solubility: the constraint that shapes every decision

Cyclodextrin	CAS	Glucose units	Cavity	Water solubility (25 °C)
α-Cyclodextrin	10016-20-3	6	4.7-5.3 Å	About 145 g/L
β-Cyclodextrin	7585-39-9	7	6.0-6.5 Å	About 18.5 g/L
γ-Cyclodextrin	17465-86-0	8	7.5-8.3 Å	About 232 g/L
Hydroxypropyl-β-cyclodextrin	varies with substitution	7 (substituted)	Similar to β	Very high – freely soluble
Sulfobutyl ether β-cyclodextrin	varies with substitution	7 (substituted)	Similar to β	Very high – freely soluble

β-cyclodextrin sits in an awkward place: its cavity is the useful size, but its solubility is the lowest of the three native forms. That single fact explains most of the substitution behaviour in the market – when a formulation needs a high concentration of complex, the formulator moves to hydroxypropyl- or sulfobutyl ether β-cyclodextrin rather than to the parent compound.

Note also that apparent solubility increases as the complex forms: adding β-cyclodextrin to a saturated solution can dissolve more guest than water would alone, even though the cyclodextrin itself is only sparingly soluble. The solubility curve is therefore not a straight line and should be measured rather than assumed.

4. Reading a specification

Item	Typical requirement	What it actually tells you
Assay	98.0-102.0%	Cyclodextrin content, on the dried basis – the range straddles 100% because the pharmacopoeial method is a titration and the hydrate is variable
Loss on drying	14.0% max	Water of crystallisation. Up to about ten waters of hydration is normal; a figure near zero means an anhydrous or over-dried material, not a better one
Specific rotation	+159° to +164°	The identity test. α- and γ-cyclodextrin rotate differently, so this is the cheapest check that the homologue is correct
Reducing sugars	1.0% max	Incomplete cyclisation or hydrolysis – a process-quality signal rather than a safety one
Light-absorbing impurities	0.10 (230-350 nm); 0.05 (350-750 nm)	Coloured or aromatic impurities; also a proxy for how well the material was purified
Chloride	0.018% max	Residual from neutralisation and ion exchange
Residue on ignition	0.1% max	Inorganic load
Heavy metals	10 ppm max	Standard; note that individual metals may be limited separately in a pharmacopoeial monograph
Residual solvent	e.g. cyclohexane 0.388% max	Process-dependent. Not every manufacturer uses a solvent; when one appears on the specification it should be checked against the ICH Q3C limit for your market
Microbial limits	1000 cfu/g total; 100 cfu/g moulds and yeasts; E. coli absent	A food-grade package. A pharmaceutical user may need tighter limits and an endotoxin figure

The assay range of 98.0-102.0% looks loose until you remember the basis: a hydrate titrated on the dried basis will legitimately land either side of 100%. Comparing that figure with a competitor’s “99%” without knowing the basis is a common and expensive mistake.

5. How the complex is actually made

Method	How it works	Best for
Solution method	Dissolve or suspend the cyclodextrin in water, add the guest, stir until equilibrium, then isolate by cooling, concentration or drying	Laboratory work and well-behaved systems; the reference method
Kneading	Work the cyclodextrin with a small amount of water and the guest to a paste, then dry	Heat-sensitive guests at small scale
Co-grinding	Ball-mill or grind the two solids together, sometimes with a little water	Solvent-free processing; solid guests
Spray drying	Dry the equilibrated solution rapidly	Production scale; gives a free-flowing powder
Supercritical or solvent-assisted	Use a supercritical fluid or a volatile co-solvent to carry the guest into the cavity	Special cases where water is incompatible

Whichever route is used, the question that decides whether the complex is real is the same: does the isolated material show the guest’s characteristic behaviour (thermal transition, spectroscopic shift, release profile) rather than the physical mixture’s? A “complex” that separates on standing was never a complex.

6. What to put on the purchase order

Homologue and CAS – alpha, beta and gamma are different products with overlapping trade names.
Assay with the basis stated plus the loss-on-drying limit, so the as-received content can be calculated.
Specific rotation on the COA – the identity check that costs nothing to request.
Residual solvent set and microbial limits matched to the end use: a food-grade package is not a pharmaceutical package.
Pharmacopoeial compliance statement if the material is going into a regulated product – and say which pharmacopoeia and edition.

7. Packaging and supply

β-cyclodextrin ships as a white crystalline powder in 25 kg fibre drums or bags with an inner liner, and in sealed development packs. Because it is a hydrate, storage humidity changes the loss-on-drying figure in both directions – keep it sealed, cool and dry, and verify the water content on receipt rather than relying on the certificate alone. Each lot is supplied with a COA and SDS, with FOB or CIF terms quoted against destination. For food or pharmaceutical destinations, state the end use at enquiry stage: the documentation package and the microbial specification follow from it, and retrofitting them after the order is always slower.

8. The honest summary

β-cyclodextrin is not a commodity filler – it is a functional excipient whose value depends entirely on whether the guest fits and whether the required concentration is reachable within its solubility. When it fits, it can turn a formulation problem into a formulation, and that is worth far more than the price difference between two lots. When it does not fit, no amount of extra cyclodextrin will help, and the answer is a different homologue or a derivative. Deciding which of those you are in is the whole job.